title: MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
abstract: Methicillin-resistant Staphylocosis aureus (MRSA) is an emerging infection in patients with cystic fibrosis (CF). MRSA may be a management dilemma for healthcare workers (HCWs) with CF. Eradication of MRSA with long-term rifampicin and fusidic acid can be achieved in patients with CF. We describe a case of recurrent MRSA infection in a HCW with CF. Molecular typing of the MRSA isolates supported re-infection rather than re-emergence of an earlier MRSA infection. Infection control advice for HCWs with CF who acquire MRSA remains controversial.
authors: Adult Cystic Fibrosis Unit, Brisbane, QLD, Australia.
authors: D G
authors: DG
authors: Downey
authors: T J
authors: TJ
authors: Kidd
authors: C
authors: C
authors: Coulter
authors: S C
authors: SC
authors: Bell
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005672:Fusidic Acid / Q000627:therapeutic use; D006282:Health Personnel; D006801:Humans; D016106:Methicillin Resistance; D012293:Rifampin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D005672:Fusidic Acid; D012293:Rifampin